Monomethyl Auristatin E (MMAE) is a synthetic analog of dolastatin 10 that similarly inhibits tubulin polymerization and exhibits potent cytotoxicity. It is commonly conjugated with monoclonal antibodies directed at antigens specific to cancer cells for tumor-directed cytotoxicity.
Structure of 474645-27-7
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| 25 mg | $298 | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
| ConcentrationVolumeMass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.3928 mL | 6.9640 mL | 13.9280 mL |
| 5 mM | 0.2786 mL | 1.3928 mL | 2.7856 mL |
| 10 mM | 0.1393 mL | 0.6964 mL | 1.3928 mL |
| 50 mM | 0.0279 mL | 0.1393 mL | 0.2786 mL |
Can you tell me more about the application of MMAE?
Dear customer, thanks for asking. According to our knowledge, monomethyl auristatin E (MMAE) is a synthetic antineoplastic agent. For its toxicity, it can't be used as a drug; instead, it is linked to a monoclonal antibody (MAB) which directs it to the cancer cells.
31/1/2019
Hello, I would like to know the activity of MMAE?
MMAE binds to the tubulin subunits of microtubules, disrupting their dynamic instability and preventing their proper function during mitosis. This leads to the formation of aberrant spindles and activation of the spindle assembly checkpoint, ultimately resulting in cell death.
01/10/2019
What is the IC50 value of MMAE in vitro?
The IC50 values of MMAE: 1-100 nM (lymphoma, leukemia, and breast cancer cells).
26/06/2020
What's the mechanism of action of MMAE?
The mechanism of action of MMAE is known, as it inhibits cell division by binding to tubulin dimers and disrupting the microtubule network.
19/12/2021
Is it stable?
The stability test indicated that MMAE was stable for the following conditions: short-term (4 h), long-term (4 weeks), freeze/thaw (3 cycles) and post-preparative stability (12 h).
27/6/2022
Preclinical studies of MMAE
In my experiment, MMAE has shown remarkable potential in targeted cancer therapy. Its conjugation to antibodies has demonstrated promising results in preclinical studies, with significant tumor regression and prolonged survival rates in animal models. I'm looking forward to seeing how this technology translates to clinical trials.
28/01/2018
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.